Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 359 clinical trials
  • 0 views
  • 10 Mar, 2026
  • 1 location
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Primary Objective: To confirm appropriate dose levels of fitusiran when administered to male pediatric participants (ages 1 to <12 years of age) with severe hemophilia A or B Secondary Objective: To characterize the safety and tolerability To characterize the pharmacokinetics (PK)

severe haemophilia a
antihemophilic factor
hemophilia
fitusiran
bethesda assay
  • 0 views
  • 04 Dec, 2020
  • 11 locations
An Open-label Ascending Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)

Primary Objective: To describe the pharmacokinetic (PK) profile of sarilumab in patients aged 2-17 years with Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) in order to identify the dose and regimen for adequate treatment of this population Secondary Objective: To describe the pharmacodynamic (PD) profile, the efficacy and the long-term safety of …

antirheumatic
anti-rheumatic drugs
rheumatoid factor
arthritis
disease modifying antirheumatic drugs
  • 0 views
  • 04 Dec, 2020
  • 33 locations
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Primary Objective: To confirm appropriate dose levels of fitusiran when administered to male pediatric participants (ages 1 to <12 years of age) with severe hemophilia A or B Secondary Objective: To characterize the safety and tolerability To characterize the pharmacokinetics (PK)

severe haemophilia a
antihemophilic factor
hemophilia
fitusiran
bethesda assay
  • 0 views
  • 04 Dec, 2020
  • 6 locations
A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)

Primary Objective: To describe the pharmacokinetic (PK) profile of sarilumab in patients aged 1-17 years with Systemic Juvenile Idiopathic Arthritis (sJIA) in order to identify the dose and regimen for adequate treatment of this population. Secondary Objective: To describe the pharmacodynamics (PD) profile, the efficacy, and the long term safety …

rheumatic diseases
arthritis
disease modifying antirheumatic drugs
glucocorticoids
fever
  • 0 views
  • 04 Dec, 2020
  • 30 locations
DemoStudyfor V4.6 Sprint Demo (CARGOx)  

The differential diagnosis of central diabetes insipidus (cDI) is difficult and the current test with the highest diagnostic accuracy is copeptin measurement after hypertonic saline infusion (HIS). Although the HIS improved diagnostic accuracy compared to the standard water deprivation test used for decades before, it still comprises great discomfort for …

  • 0 views
  • 11 May, 2022
  • 6 locations
V6.3 Additional &QA123  

Test Comment here

  • 0 views
  • 24 Aug, 2023
  • 4 locations
The Benefit of a Deep Cleansing Gel in the Management of Mild to Moderate Truncal Acne  

Acne vulgaris is a chronic inflammatory disease, mainly of the face, but also of the trunk. Acne may be caused by internal and external factors. Only a very small amount of data exists concerning truncal acne. The condition affects about 9% of the population worldwide, with 50% of subjects with …

  • 0 views
  • 16 Dec, 2022
  • 6 locations
  • 0 views
  • 04 Aug, 2023
  • 3 locations
  • 0 views
  • 24 May, 2024
  • 2 locations